Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells

Circulation

Volumn 99, Issue 9, 1999, Pages 1230-1235

  Ikeda, Uichi ^a   Ikeda, Michiyo ^a   Minota, Seiji ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Free radicals; Homocysteine; Interleukins; Muscle, smooth; Nitric oxide

Indexed keywords

CYSTEINE; CYTOKINE; GLUTATHIONE; HOMOCYSTEINE; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; NITRIC OXIDE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; HYPERHOMOCYSTEINEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0033537666     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.9.1230     Document Type: Article

References (39)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-140.
2. Nathan C, Xie Q. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994;269:13725-13728.
3. Shindo T, Ikeda U, Ohkawa F, Takahashi M, Funayama H, Nishinaga M, Kawahara Y, Yokoyama M, Shimada K. Nitric oxide synthesis in rat cardiac myocytes and fibroblasts. Life Sci. 1994;55:1101-1108.
4. Koide M, Kawahara Y, Tsuda T, Yokoyama M. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 1993;318:213-217.
5. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation. Circ Res. 1993;73:217-222.
6. Joly GA, Schini VB, Vanhoutte PM. Balloon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries. Circ Res. 1992;71:331-338.
7. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77-85.
8. Mudd SH, Skovby FS, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Grobe H, Schmidt H, Schweitzer C. The natural history of homocystinuria due to cystathione β-synthase deficiency. Am J Hum Genet. 1985;37:1-31.
9. Selhub J, D'Angelo A. Hyperhomocysteinemia and thrombosis: acquired conditions. Thromb Haemost. 1997;78:527-531.
10. Selhub J, Jacques PF, Bostom AG, D'Agostino RB. Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocyst(e)ine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-291.
11. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
12. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Henneckens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Assoc. 1992;268:877-881.
13. Mainlow MR. Hyperhomocysteinemia: a common and easily reversible risk factor for occlusive atherosclerosis. Circulation. 1990;81: 2004-2006.
14. Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia: vascular injury and arterial thrombosis. N Engl J Med. 1974;291:537-543.
15. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274: 1049-1057.
16. Harker LA, Ross R, Slichter SJ, Scott CR. Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58:731-741.
17. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activation. J Clin Invest. 1986;77:1909-1916.
18. Hayashi T, Honda G, Suzuki K. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood. 1992;79:2930-2936.
19. Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 1990;75:895-901.
20. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the tnrombogenic agent homocysteine. J Clin Invest. 1991;88:1906-1914.
21. Nishinaga M, Ozawa T, Shimada K. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 1993;92:1381-1386.
22. Tsai J, Perrella MA, Yoshizumi M, Hsieh C, Haber E, Schlegel R, Lee M. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 1994;91:6369-6373.
23. Welch GN, Upchurch GR Jr, Farivar RS, Pigazzi A, Vu K, Brecher P, Keaney JF Jr, Loscalzo J. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-κB-dependent transcriptional activation of Nos 2. Proc Assoc Am Physicians. 1998;110:22-31.
24. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol. 1991;260:H1713-H1717.
25. Ikeda U, Kanbe T, Kawahara Y, Yokoyama M, Shimada K. Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Circulation. 1996;94:2560-2565.
26. 15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
27. Ikeda U, Kurosaki K, Shimpo M, Okada K, Saito T, Shimada K. Adenosine stimulates nitric oxide synthesis in rat cardiac myocytes. Am J Physiol. 1997;273:H59-H65.
28. Wall RT, Horlan JM, Harker LA, Striker GE. Homocyst(e)ine-induced endothelial injury in vitro: a model for the study of vascular injury. Thromb Res. 1980;18:113-121.
29. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocyst(e)ine. J Clin Invest. 1986;77:1370-1376.
30. Lentz SR, Sadler JE. Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood. 1993;81:683-689.
31. Hajjar KA. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest. 1993;91:2873-2879.
32. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308-318.
33. Tsai J, Wang H, Perrella MA, Yoshizumi M, Sibinga NES, Tan LC, Haber E, Chang TH, Schlegel R, Lee M. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest. 1996;97:146-153.
34. Hansson GK, Geng Y, Holm J, Hårdhammar P, Wennmalm Å, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733-738.
35. Wennmalm Å. Endothelial nitric oxide and cardiovascular disease. J Intern Med. 1994;235:317-327.
36. Lloyd-Jones D, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med. 1996;47:365-375.
37. Yan Z, Yokota T, Zhang W, Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res. 1996;79:38-44.
38. Hamon M, Vallet B, Bauters C, Wernert N, McFadden EP, Lablanche JM, Dupuis B, Bertrand ME. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation. 1994; 90:1357-1362.
39. Shears II LL, Kawaharada N, Tzeng E, Billiar TR, Watkins SC, Kovesdi I, Lizonova A, Pham SM. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest. 1997;100: 2035-2042.